PBRM1 deficiency enhances PD1 immunotherapeutic sensitivity via chromosomal accessibility in colorectal cancer
Theranostics · 2025
DOI: 10.7150/thno.100793 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Rui Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Shunde Hospital of Southern Medical University, Foshan, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Drug Resistance, Neoplasm, Immune Checkpoint Inhibitors, DNA-Binding Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Our study established that PBRM1/Pbrm1 deficiency was positively correlated with PD1 immunotherapeutic sensitivity in colorectal cancer. The underlying molecular mechanisms involved regulation of chromosome accessibility, activation of the NF-κB signaling pathway, and immune cell infiltration in the microenvironment. These findings identify potential molecular targets for enhancing immunotherapy for colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Shunde Hospital of Southern Medical University, Foshan, China.
- Department of Pathology & Guangdong Province Key Laboratory of Molecular Tumor Pathology, Basic Medical College, Southern Medical University, Guangzhou, China.
- Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Live…
Zitieren
APA
Li, R., He, J., Liu, C., Jiang, Z., Qin, J., Liang, K., Ji, Z., & Zhao, L. (2025). PBRM1 deficiency enhances PD1 immunotherapeutic sensitivity via chromosomal accessibility in colorectal cancer. Theranostics. https://doi.org/10.7150/thno.100793
Vancouver
Li R, He J, Liu C, Jiang Z, Qin J, Liang K, et al. PBRM1 deficiency enhances PD1 immunotherapeutic sensitivity via chromosomal accessibility in colorectal cancer. Theranostics. 2025. doi:10.7150/thno.100793
BibTeX
@article{Li2025,
author = {Li, Rui and He, Jie and Liu, Chaoqun and Jiang, Zesheng and Qin, Jiasheng and Liang, Kun and Ji, Zhuocheng and Zhao, Liang},
title = {PBRM1 deficiency enhances PD1 immunotherapeutic sensitivity via chromosomal accessibility in colorectal cancer},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.100793}
}
EUVIMED